Literature DB >> 1588558

4'-modified analogues of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase.

M S Wolfe1, Y Lee, W J Bartlett, D R Borcherding, R T Borchardt.   

Abstract

The carbocyclic adenosine analogues aristeromycin and neplanocin A both display significant S-adenosyl-L-homocysteine (AdoHcy) hydrolase inhibitory activity and broad-spectrum antiviral effects. Since phosphorylation of the 4'-hydroxymethyl substituent has been implicated with the cytotoxicity of these compounds, various analogues modified at this position were synthesized utilizing a key cyclopentenone intermediate 3 which can be derived from several members of the natural chiral pool. Cyclopentenone 3 underwent a highly stereoselective conjugate addition with organocuprate reagents, and the 1,4-adducts so formed were then readily elaborated to the corresponding 4'-modified aristeromycin analogues. Alternatively, quenching the enolate intermediate of the organocuprate conjugate addition with methanesulfinyl chloride followed by pyrolytic syn elimination resulted in the formation of 4'-modified neplanocin A intermediates. Three of the final compounds (1b, 1c, and 1e) displayed inhibitory activity toward AdoHcy hydrolase in the nanomolar range.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588558     DOI: 10.1021/jm00088a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Synthesis and antitrypanosomal activities of a series of 7-deaza-5'-noraristeromycin derivatives with variations in the cyclopentyl ring substituents.

Authors:  K L Seley; S W Schneller; D Rattendi; S Lane; C J Bacchi
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Synthesis of the 6'-iso analogues of neplanocin A and 5'-homoneplanocin A.

Authors:  Wei Ye; Mingzhu He; Stewart W Schneller
Journal:  Tetrahedron Lett       Date:  2009-12-23       Impact factor: 2.415

3.  Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.

Authors:  Paola Ruiz Puentes; Laura Rueda-Gensini; Natalia Valderrama; Isabela Hernández; Cristina González; Laura Daza; Carolina Muñoz-Camargo; Juan C Cruz; Pablo Arbeláez
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

4.  Synthesis and anti-hepatitis B virus and anti-hepatitis C virus activities of 7-deazaneplanocin A analogues in vitro.

Authors:  Hyo-Joong Kim; Ashoke Sharon; Chandralata Bal; Jianing Wang; Madhan Allu; Zhuhui Huang; Michael G Murray; Leda Bassit; Raymond F Schinazi; Brent Korba; Chung K Chu
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

5.  Carbocyclic 4'-Epiformycin.

Authors:  Jian Zhou; Minmin Yang; Akin Akdag; Haisheng Wang; Stewart W Schneller
Journal:  Tetrahedron       Date:  2008-01-07       Impact factor: 2.457

6.  Design and synthesis of a series of truncated neplanocin fleximers.

Authors:  Sarah C Zimmermann; Elizaveta O'Neill; Godwin U Ebiloma; Lynsey J M Wallace; Harry P De Koning; Katherine L Seley-Radtke
Journal:  Molecules       Date:  2014-12-16       Impact factor: 4.411

7.  Design, Synthesis, and Anti-RNA Virus Activity of 6'-Fluorinated-Aristeromycin Analogues.

Authors:  Ji-Seong Yoon; Gyudong Kim; Dnyandev B Jarhad; Hong-Rae Kim; Young-Sup Shin; Shuhao Qu; Pramod K Sahu; Hea Ok Kim; Hyuk Woo Lee; Su Bin Wang; Yun Jeong Kong; Tong-Shin Chang; Natacha S Ogando; Kristina Kovacikova; Eric J Snijder; Clara C Posthuma; Martijn J van Hemert; Lak Shin Jeong
Journal:  J Med Chem       Date:  2019-06-20       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.